MYEZOM 2MG INJ is a Schedule H drug. MYEZOM 2MG INJ is composed of: BORTEZOMIB (2 MG)
Tag: medicine for mantle cell lymphoma
LENZEST 5MG CAP
LENZEST 5MG CAP is a Schedule H drug. LENZEST 5MG CAP is composed of: LENALIDOMIDE (5 MG)
LENOMUST 5 MG CAP
LENOMUST 5 MG CAP is a Schedule H drug. LENOMUST 5 MG CAP is composed of: LENALIDOMIDE (5 MG)
LENOME 5MG CAP
LENOME 5MG CAP is a Schedule H drug. LENOME 5MG CAP is composed of: LENALIDOMIDE (5 MG)
LENANGIO 25MG CAP
LENANGIO 25MG CAP is a Schedule H drug. LENANGIO 25MG CAP is composed of: LENALIDOMIDE (25 MG)
LENANGIO 10MG CAP
LENANGIO 10MG CAP is a Schedule H drug. LENANGIO 10MG CAP is composed of: LENALIDOMIDE (10 MG)
LENALID 10MG CAP
LENALID 10MG CAP is a Schedule H drug. LENALID 10MG CAP is composed of: LENALIDOMIDE (10 MG)
BIOCURE INJ
BIOCURE INJ is a Schedule H drug. BIOCURE INJ is composed of: BORTEZOMIB (2 MG)
BORTETOR 2MG INJ
BORTETOR 2MG INJ is a Schedule H drug. BORTETOR 2MG INJ is composed of: BORTEZOMIB (2 MG)
LENALIDOMIDE
LENALIDOMIDE is a Schedule H drug.